Human SNP ID | rs3106136 |
---|---|
Human chromosome | chr4 |
Human SNP position | 94232198 |
Pig chromosome | chr8 |
Pig SNP position | 134752110 |
PubMed ID | 22864933 |
---|---|
Journal | Cancer |
Link | www.ncbi.nlm.nih.gov/pubmed/22864933 |
Study | Identification of novel germline polymorphisms governing capecitabine sensitivity. |
Disease/Trait | Capecitabine sensitivity |
Initial sample | Up to 84 East Asian ancestry lymphoblastoid cell lines, up to 164 European ancestry lymphoblastoid cell lines, up to 173 African ancestry lymphoblastoid cell lines, up to 82 African American lymphoblastoid cell lines |
Replication sample | NA |
Region | 4q22.3 |
Chromosome id | chr4 |
Chromosome position | 94232198 |
Reported gene | SMARCAD1 |
Mapped gene | SMARCAD1 |
Upstream gene id | |
Downstream gene id | |
SNP gene ids | 56916 |
Upstream gene distance | |
Downstream gene distance | |
SNP risk allele | rs3106136-? |
SNPs | rs3106136 |
Merged | 0 |
SNP id current | 3106136 |
Context | intron_variant |
Intergenic | 0 |
Allele frequency | NR |
P value | 0.000007 |
Pvalue mlog | 5.15490195998574 |
P value text | |
Or beta | |
%95 Ci | |
Platform | NR [~ 2000000] |
CNV | N |
Mapped trait | response to antineoplastic agent |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097327 |
Study accession | GCST001368 |